You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日速報》恆指跌331點; 恆生科技指數跌119點 阿里巴巴跌逾3% 中生製藥、紫金礦業、藥明康德、翰森製藥、周大福創新高 成交暢旺
恆指全日收24,035點,跌331點或1.4%。恆生科技指數報5,331點,跌119點或2.2%。國指跌135點或1.5%,報8,729點。大市成交額2,444.12億元。 活躍重磅股表現: 阿里巴巴(09988.HK) 收114.6元,下跌3.2%; 港交所(00388.HK) 收411.4元,下跌2.1%; 美團(03690.HK) 收141元,下跌1.9%; 友邦(01299.HK) 收68.9元,下跌1.8%; 騰訊(00700.HK) 收510元,下跌1.5%; 平安(02318.HK) 收48.55元,下跌0.4%; 建行(00939.HK) 收7.64元,下跌0.1%; 異動恆指及國指成份股: 中生製藥(01177.HK) 收5.69元,上升19.3%,創新高; 小鵬汽車(09868.HK) 收76.35元,下跌6.7%; 百威亞太(01876.HK) 收8.06元,下跌6.4%; 百濟神州(06160.HK) 收168.5元,上升6%; 快手-W(01024.HK) 收58.55元,下跌5.9%; 紫金礦業(02899.HK) 收20元,上升4.9%,創新高; 藥明康德(02359.HK) 收78.45元,上升4.7%,創新高; 比亞迪(01211.HK) 收134.4元,下跌4.5%; 藥明生物(02269.HK) 收27.75元,上升4.1%; 翰森製藥(03692.HK) 收29.9元,上升3.8%,創新高; 海底撈(06862.HK) 收15.02元,下跌3.6%; 小米集團(01810.HK) 收52.2元,下跌3.5%; 阿里健康(00241.HK) 收4.75元,上升3.3%; 周大福(01929.HK) 收12.28元,上升2.2%,創新高; 異動綜合中小型股: 獅騰控股(02562.HK) 收22.7元,上升16.8%; 健康之路(02587.HK) 收50.25元,下跌12.7%; 美中嘉和(02453.HK) 收7.28元,上升11.3%; 藥師幫(09885.HK) 收11.2元,上升10.9%; 平安好醫生(01833.HK) 收8.11元,上升10.8%; 順豐同城(09699.HK) 收16.64元,上升10.6%,創新高; 先健科技(01302.HK) 收1.89元,上升10.5%; 丘鈦(01478.HK) 收7.5元,上升10.3%; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account